Page last updated: 2024-11-07

dehydroepiandrosterone and Adrenoleukodystrophy, Autosomal Neonatal Form

dehydroepiandrosterone has been researched along with Adrenoleukodystrophy, Autosomal Neonatal Form in 3 studies

Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Depreter, M2
Vandesompele, J2
Espeel, M1
Speleman, F2
Roels, F2
Ferdinandusse, S1
Smith, KJ1
Skelton, HG1

Other Studies

3 other studies available for dehydroepiandrosterone and Adrenoleukodystrophy, Autosomal Neonatal Form

ArticleYear
Modulation of the peroxisomal gene expression pattern by dehydroepiandrosterone and vitamin D: therapeutic implications.
    The Journal of endocrinology, 2002, Volume: 175, Issue:3

    Topics: Animals; Base Sequence; Calcifediol; Catalase; Contraindications; Dehydroepiandrosterone; DNA Primer

2002
Regulation of peroxisomal genes by DHEA and vitamin D.
    Advances in experimental medicine and biology, 2003, Volume: 544

    Topics: Animals; Catalase; Dehydroepiandrosterone; Female; Gene Expression Regulation; Humans; Liver; Peroxi

2003
Peroxisomal proliferator-activated ligand therapy for HIV lipodystrophy.
    Clinical and experimental dermatology, 2001, Volume: 26, Issue:2

    Topics: Anti-HIV Agents; Cyclooxygenase Inhibitors; Dehydroepiandrosterone; Drug Therapy, Combination; HIV I

2001